Cargando…

The molecular targets of ivermectin and lotilaner in the human louse Pediculus humanus humanus: New prospects for the treatment of pediculosis

Control of infestation by cosmopolitan lice (Pediculus humanus) is increasingly difficult due to the transmission of parasites resistant to pediculicides. However, since the targets for pediculicides have no been identified in human lice so far, their mechanisms of action remain largely unknown. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamassiaude, Nicolas, Toubate, Berthine, Neveu, Cédric, Charnet, Pierre, Dupuy, Catherine, Debierre-Grockiego, Françoise, Dimier-Poisson, Isabelle, Charvet, Claude L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891696/
https://www.ncbi.nlm.nih.gov/pubmed/33600484
http://dx.doi.org/10.1371/journal.ppat.1008863
_version_ 1783652753614045184
author Lamassiaude, Nicolas
Toubate, Berthine
Neveu, Cédric
Charnet, Pierre
Dupuy, Catherine
Debierre-Grockiego, Françoise
Dimier-Poisson, Isabelle
Charvet, Claude L.
author_facet Lamassiaude, Nicolas
Toubate, Berthine
Neveu, Cédric
Charnet, Pierre
Dupuy, Catherine
Debierre-Grockiego, Françoise
Dimier-Poisson, Isabelle
Charvet, Claude L.
author_sort Lamassiaude, Nicolas
collection PubMed
description Control of infestation by cosmopolitan lice (Pediculus humanus) is increasingly difficult due to the transmission of parasites resistant to pediculicides. However, since the targets for pediculicides have no been identified in human lice so far, their mechanisms of action remain largely unknown. The macrocyclic lactone ivermectin is active against a broad range of insects including human lice. Isoxazolines are a new chemical class exhibiting a strong insecticidal potential. They preferentially act on the γ-aminobutyric acid (GABA) receptor made of the resistant to dieldrin (RDL) subunit and, to a lesser extent on glutamate-gated chloride channels (GluCls) in some species. Here, we addressed the pediculicidal potential of isoxazolines and deciphered the molecular targets of ivermectin and the ectoparasiticide lotilaner in the human body louse species Pediculus humanus humanus. Using toxicity bioassays, we showed that fipronil, ivermectin and lotilaner are efficient pediculicides on adult lice. The RDL (Phh-RDL) and GluCl (Phh-GluCl) subunits were cloned and characterized by two-electrode voltage clamp electrophysiology in Xenopus laevis oocytes. Phh-RDL and Phh-GluCl formed functional homomeric receptors respectively gated by GABA and L-glutamate with EC(50) values of 16.0 μM and 9.3 μM. Importantly, ivermectin displayed a super agonist action on Phh-GluCl, whereas Phh-RDL receptors were weakly affected. Reversally, lotilaner strongly inhibited the GABA-evoked currents in Phh-RDL with an IC(50) value of 40.7 nM, whereas it had no effect on Phh-GluCl. We report here for the first time the insecticidal activity of isoxazolines on human ectoparasites and reveal the mode of action of ivermectin and lotilaner on GluCl and RDL channels from human lice. These results emphasize an expected extension of the use of the isoxazoline drug class as new pediculicidal agents to tackle resistant-louse infestations in humans.
format Online
Article
Text
id pubmed-7891696
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-78916962021-02-25 The molecular targets of ivermectin and lotilaner in the human louse Pediculus humanus humanus: New prospects for the treatment of pediculosis Lamassiaude, Nicolas Toubate, Berthine Neveu, Cédric Charnet, Pierre Dupuy, Catherine Debierre-Grockiego, Françoise Dimier-Poisson, Isabelle Charvet, Claude L. PLoS Pathog Research Article Control of infestation by cosmopolitan lice (Pediculus humanus) is increasingly difficult due to the transmission of parasites resistant to pediculicides. However, since the targets for pediculicides have no been identified in human lice so far, their mechanisms of action remain largely unknown. The macrocyclic lactone ivermectin is active against a broad range of insects including human lice. Isoxazolines are a new chemical class exhibiting a strong insecticidal potential. They preferentially act on the γ-aminobutyric acid (GABA) receptor made of the resistant to dieldrin (RDL) subunit and, to a lesser extent on glutamate-gated chloride channels (GluCls) in some species. Here, we addressed the pediculicidal potential of isoxazolines and deciphered the molecular targets of ivermectin and the ectoparasiticide lotilaner in the human body louse species Pediculus humanus humanus. Using toxicity bioassays, we showed that fipronil, ivermectin and lotilaner are efficient pediculicides on adult lice. The RDL (Phh-RDL) and GluCl (Phh-GluCl) subunits were cloned and characterized by two-electrode voltage clamp electrophysiology in Xenopus laevis oocytes. Phh-RDL and Phh-GluCl formed functional homomeric receptors respectively gated by GABA and L-glutamate with EC(50) values of 16.0 μM and 9.3 μM. Importantly, ivermectin displayed a super agonist action on Phh-GluCl, whereas Phh-RDL receptors were weakly affected. Reversally, lotilaner strongly inhibited the GABA-evoked currents in Phh-RDL with an IC(50) value of 40.7 nM, whereas it had no effect on Phh-GluCl. We report here for the first time the insecticidal activity of isoxazolines on human ectoparasites and reveal the mode of action of ivermectin and lotilaner on GluCl and RDL channels from human lice. These results emphasize an expected extension of the use of the isoxazoline drug class as new pediculicidal agents to tackle resistant-louse infestations in humans. Public Library of Science 2021-02-18 /pmc/articles/PMC7891696/ /pubmed/33600484 http://dx.doi.org/10.1371/journal.ppat.1008863 Text en © 2021 Lamassiaude et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lamassiaude, Nicolas
Toubate, Berthine
Neveu, Cédric
Charnet, Pierre
Dupuy, Catherine
Debierre-Grockiego, Françoise
Dimier-Poisson, Isabelle
Charvet, Claude L.
The molecular targets of ivermectin and lotilaner in the human louse Pediculus humanus humanus: New prospects for the treatment of pediculosis
title The molecular targets of ivermectin and lotilaner in the human louse Pediculus humanus humanus: New prospects for the treatment of pediculosis
title_full The molecular targets of ivermectin and lotilaner in the human louse Pediculus humanus humanus: New prospects for the treatment of pediculosis
title_fullStr The molecular targets of ivermectin and lotilaner in the human louse Pediculus humanus humanus: New prospects for the treatment of pediculosis
title_full_unstemmed The molecular targets of ivermectin and lotilaner in the human louse Pediculus humanus humanus: New prospects for the treatment of pediculosis
title_short The molecular targets of ivermectin and lotilaner in the human louse Pediculus humanus humanus: New prospects for the treatment of pediculosis
title_sort molecular targets of ivermectin and lotilaner in the human louse pediculus humanus humanus: new prospects for the treatment of pediculosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891696/
https://www.ncbi.nlm.nih.gov/pubmed/33600484
http://dx.doi.org/10.1371/journal.ppat.1008863
work_keys_str_mv AT lamassiaudenicolas themoleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT toubateberthine themoleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT neveucedric themoleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT charnetpierre themoleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT dupuycatherine themoleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT debierregrockiegofrancoise themoleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT dimierpoissonisabelle themoleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT charvetclaudel themoleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT lamassiaudenicolas moleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT toubateberthine moleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT neveucedric moleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT charnetpierre moleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT dupuycatherine moleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT debierregrockiegofrancoise moleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT dimierpoissonisabelle moleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis
AT charvetclaudel moleculartargetsofivermectinandlotilanerinthehumanlousepediculushumanushumanusnewprospectsforthetreatmentofpediculosis